儿童ARDS早期血浆基质金属蛋白酶谱:一种新通路
该研究在2008至2017年五家医院235例儿童ARDS患者中,检测第1天血浆MMPs,用潜在类别分析识别不同MMP谱,并关联炎症、内皮损伤、氧合及临床结局。约三分之一患者呈现特定MMP谱,其死亡或严重并发症风险增加四倍,且联合P/F比值与MMP谱的预后模型优于单用P/F比值。
要点
- 儿童ARDS第1天血浆MMP谱可识别约三分之一高危患者。
- 特定MMP谱与炎症、内皮损伤、氧合障碍及不良预后独立相关。
- 联合P/F比值与MMP谱可提升死亡或严重并发症的预后判别。
核心结论
- 儿童ARDS患者存在特定血浆MMP谱,与炎症、内皮损伤、发病率及死亡率相关。
研究设计与样本
- 研究纳入2008至2017年五家医院235例儿童ARDS患者,检测第1天血浆MMPs。
- 采用潜在类别分析识别不同MMP谱,并在地理上不同的推导与验证队列中评估。
主要发现
- 约三分之一患者呈现MMP-1、-2、-3、-7、-8及TIMP-1、-2升高而活性及总MMP-9降低的MMP谱。
- 该MMP谱与第1天多种炎症标志物、内皮损伤标志物及氧合障碍相关。
- 该MMP谱独立于P/F比值及其他混杂因素,使死亡或严重并发症的比值比增加四倍(95%CI 2.1-7.6;P < 0.001)。
- 联合P/F比值与MMP谱的logistic回归预后死亡或严重并发症的AUC为0.75(95%CI 0.68-0.82),优于单用P/F比值的AUC 0.66(95%CI 0.58-0.73),P = 0.009。
临床怎么用
- 儿童ARDS早期可检测血浆MMP谱以辅助识别炎症、内皮损伤及不良预后高危患者。
- 预后评估时可考虑联合P/F比值与MMP谱,较单用P/F比值提升判别能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: MMPs (Matrix metalloproteinases) and their endogenous tissue inhibitors may contribute to lung injury through extracellular matrix degradation and modulation of inflammation and fibrosis. OBJECTIVES: To test for an association between MMP pathway proteins and inflammation, endothelial dysfunction, and clinical outcomes. METHODS: We measured MMPs in plasma collected on acute respiratory distress syndrome (ARDS) Day 1 from 235 children at five hospitals between 2008 and 2017. We used latent class analysis to identify patients with distinct MMP profiles and then associated those profiles with markers of inflammation (IL-1RA, -6, -8, -10, and -18; macrophage inflammatory protein-1α and -1β; tumor necrosis factor-α and -R2), endothelial injury (angiopoietin-2, von Willebrand factor, soluble thrombomodulin), impaired oxygenation (PaO2/FiO2 [P/F] ratio, oxygenation index), morbidity, and mortality. MEASUREMENTS AND MAIN RESULTS: In geographically distinct derivation and validation cohorts, approximately one-third of patients demonstrated an MMP profile characterized by elevated MMP-1, -2, -3, -7, and -8 and tissue inhibitor of metalloproteinase-1 and -2; and depressed active and total MMP-9. This MMP profile was associated with multiple markers of inflammation, endothelial injury, and impaired oxygenation on Day 1 of ARDS, and conferred fourfold increased odds of mortality or severe morbidity independent of the P/F ratio and other confounders (95% confidence interval, 2.1-7.6; P < 0.001). Logistic regression using both the P/F ratio and MMP profiles was superior to the P/F ratio alone in prognosticating mortality or severe morbidity (area under the receiver operating characteristic curve, 0.75; 95% confidence interval, 0.68-0.82 vs. area under the receiver operating characteristic curve, 0.66; 95% confidence interval, 0.58-0.73; P = 0.009). CONCLUSIONS: Pediatric patients with ARDS have specific plasma MMP profiles associated with inflammation, endothelial injury, morbidity, and mortality. MMPs may play a role in the pathobiology of children with ARDS.
引用
- Zinter MS, Delucchi KL, Kong MY, et al. Early Plasma Matrix Metalloproteinase Profiles. A Novel Pathway in Pediatric Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2019. PMID: 30114376. doi:10.1164/rccm.201804-0678OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。